AM Best removes Sovag from review after capital infusion
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • X
  • LinkedIn
  • Email
  • Free trial
  • Log in

AM Best removes Sovag from review after capital infusion

Catrin Shi
27 March 2017
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • X
  • LinkedIn
  • Email

AM Best affirmed the ratings of Schwarzmeer und Ostsee Versicherungsaktiengesellschaft (Sovag) and removed it from being under review with negative implications after a "material" capital injection from its shareholders.

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News
catrin shi/catrin shi ii red.png
Catrin Shi
Editor-in-Chief
Contact
Gift this article